Amoydx

15 /Aug

AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China

We are thrilled to announce that AmoyDx reaches a new collaboration agreement with AstraZeneca. Under this agreement, the AmoyDx^® Essential NGS panel will be used as a companion diagnostic of ENHERTU^® to identify HER2 (ERBB2) mutations in patients with no

27 /Mar

AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx^® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) as a companion diagnostic for RET fusion-positive non-small cell lung cancer (“NSCLC”), for selpercatinib capsules 40 mg

24 /Mar

AmoyDx will be attending the 2023 AACR Annual Meeting in Florida

Say hello to us at booth 1220 and learn more about our companion diagnostic solutions.

25 /Nov

Career Opportunities - The Field Application Scientist

The Field Application Scientist is responsible for system usage training at customer sites while providing PCR/NGS experimental design, data analysis, logistical, and troubleshooting support for LATAM.

15 /Aug AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China
27 /Mar AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
24 /Mar AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
25 /Nov Career Opportunities - The Field Application Scientist

more 

25 /Nov

Career Opportunities - Business Manager (EMEA)

You are looking for opportunities to bring to use your knowledge of and experience in oncology molecular diagnostics in qPCR and Next Generation Sequencing application? You are passionate in building meaningful relationship with both internal and external

17 /Nov

AmoyDx^® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS^® (Sotorasib)

Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx^® Pan Lung Cancer PCR Panel (the “AmoyD

17 /Nov

AmoyDx Distributors Annual Meeting 2022

AmoyDx celebrated its regular distributors annual meeting on November 15-16 in Dusseldorf Germany.

19 /Aug

Investigators Present Significant Research During WCLC 2022

Several key researches supported by Amoy Diagnostics were presented at WCLC 2022. The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from mor

25 /Nov Career Opportunities - Business Manager (EMEA)
17 /Nov AmoyDx^® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS^® (Sotorasib)
17 /Nov AmoyDx Distributors Annual Meeting 2022
19 /Aug Investigators Present Significant Research During WCLC 2022

more 

17 /Aug

AmoyDx® Master Panel--Study Reveals Clinically Relevant Intertumoral Heterogeneity of NSCLCs Driven by MET Exon 14 Skipping Mutation

Vienna – Aug. 7th, 2022. – A study presented at the IASLC World Conference on Lung Cancer 2022 in Vienna disclosed the clinically relevant intertumoral heterogeneity of non-small cell lung cancer (NSCLC) driven by MET exon 14 skipping (METex14 skipping).

17 /Aug

Amoy Diagnostics and Roche Pharma China Jointly Announce Strategic Partnership

The 2nd Roche Pan-Tumor Precision Medicine Innovation Forum was officially held at the Shanghai Roche Pharmaceuticals Campus, where participants had discussions on recent progresses in this field.

09 /Aug

MHLW Approves AmoyDx^® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek^® (Entrectinib) in Japan

TOKYO and XIAMEN, August 9, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the AmoyDx^® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) had been approved by t

08 /Jul

Visit AmoyDx at IASLC 2022 World Conference on Lung Cancer in Vienna, Austria from August 6 – 9,

AmoyDx is excited to join the IASLC 2022 World Conference on Lung Cancer (Booth# 307), held in person with virtual elements in Vienna, Austria from August 6 – 9, 2022.

17 /Aug AmoyDx® Master Panel--Study Reveals Clinically Relevant Intertumoral Heterogeneity of NSCLCs Driven by MET Exon 14 Skipping Mutation
17 /Aug Amoy Diagnostics and Roche Pharma China Jointly Announce Strategic Partnership
09 /Aug MHLW Approves AmoyDx^® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek^® (Entrectinib) in Japan
08 /Jul Visit AmoyDx at IASLC 2022 World Conference on Lung Cancer in Vienna, Austria from August 6 – 9,

more 

05 /May

20 /Apr

18 /Apr

13 /Apr

05 /May Visit AmoyDx at 2022 ASCO Annual Meeting in Chicago, IL, USA
20 /Apr Filing Notice for a Manufacturing and Marketing Application for AmoyDx^® Pan Lung Cancer PCR Panel as a Companion Diagnostic for a Drug Targeting RET fusion-Positive Non-Small Cell Lung Cancer
18 /Apr AmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and Japan
13 /Apr Beckman Coulter Life Sciences and Amoy Diagnostics Sign Application Development Agreement for the Biomek Ngenius Next Generation Library Prep System

more 

Better life with AmoyDx

Better life with AmoyDx

AmoyDx won the Second Prize of National Scientific and Technological Progress Award

Better life with AmoyDx

ABOUT AMOYDX

Latest News

AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China

AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC

AmoyDx will be attending the 2023 AACR Annual Meeting in Florida

Career Opportunities - The Field Application Scientist

Career Opportunities - Business Manager (EMEA)

AmoyDx^® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS^® (Sotorasib)

AmoyDx Distributors Annual Meeting 2022

Investigators Present Significant Research During WCLC 2022

AmoyDx® Master Panel--Study Reveals Clinically Relevant Intertumoral Heterogeneity of NSCLCs Driven by MET Exon 14 Skipping Mutation

Amoy Diagnostics and Roche Pharma China Jointly Announce Strategic Partnership

MHLW Approves AmoyDx^® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek^® (Entrectinib) in Japan

Visit AmoyDx at IASLC 2022 World Conference on Lung Cancer in Vienna, Austria from August 6 – 9,

New Products

New Products

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

ESMO Asia

AMP

Stock Info

Better life with AmoyDx

Better life with AmoyDx

AmoyDx won the Second Prize of National Scientific and Technological Progress Award

Better life with AmoyDx

ABOUT AMOYDX

Latest News

AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China

AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC

AmoyDx will be attending the 2023 AACR Annual Meeting in Florida

Career Opportunities - The Field Application Scientist

Career Opportunities - Business Manager (EMEA)

AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS® (Sotorasib)

AmoyDx Distributors Annual Meeting 2022

Investigators Present Significant Research During WCLC 2022

AmoyDx® Master Panel--Study Reveals Clinically Relevant Intertumoral Heterogeneity of NSCLCs Driven by MET Exon 14 Skipping Mutation

Amoy Diagnostics and Roche Pharma China Jointly Announce Strategic Partnership

MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek® (Entrectinib) in Japan

Visit AmoyDx at IASLC 2022 World Conference on Lung Cancer in Vienna, Austria from August 6 – 9,

New Products

New Products

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

Pan Lung Cancer PCR Panel

HANDLE Classic NGS Panel

HRD Focus Panel

BRCA Pro Panel

ESMO Asia

AMP

Stock Info

AmoyDx^® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS^® (Sotorasib)

MHLW Approves AmoyDx^® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek^® (Entrectinib) in Japan